Exosomes are a family of bioactive vesicles and play important roles in antigen presentation. A recent phase I clinical trial with an exosome vaccine derived from colorectal cancer has shown minor clinical benefit. Exosomes derived from leukaemia cell lines have been little studied so, in the present study, the immunoprotective effect of exosomes secreted by NB4 cells, a human acute promyelocytic leukaemia cell line, was investigated. NB4-derived exosomes expressed the proteins retinoic acid receptor a and interstitial cell adhesion molecule 1 and contained heat shock protein 70, as demonstrated by transmission electron microscopy and Western blotting. Cytotoxicity assay demonstrated that cytotoxic T lymphocytes (CTLs) induced by dendritic cells (DCs) pulsed with exosomes were significantly more effective in killing target NB4 cells than CTLs induced by DCs alone. Exosome-based vaccines may be a promising means of prolonging disease-free survival in acute promyelocytic leukaemia patients after induction therapy.
ZitvogelLRegnaultALozierA: Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat Med1998; 4: 594–600.
5.
BlanchardNLankarDFaureF: TCR activation of human T cells induces the production of exosomes bearing the TCR/CD3/ζ complex. J Immunol2002; 168: 3235–3241.
HeijnenHFSchielAEFijnheerR: Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and α-granules. Blood1999; 94: 3791–3799.
MarzescoAMJanichPWilsch-BrauningerM: Release of extracellular membrane particles carrying the stem cell marker prominin-1 (CD133) from neural progenitors and other epithelial cells. J Cell Sci2005; 118: 2849–2858.
10.
HegmansJPBardMPHemmesA: Proteomic analysis of exosomes secreted by human mesothelioma cells. Am J Pathol2004; 164: 1807–1815.
11.
EscolaJMKleijmeerMJStoorvogelW: Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes. J Biol Chem1998; 273: 20121–20127.
12.
HwangIShenXSprentJ: Direct stimulation of naive T cells by membrane vesicles from antigen-presenting cells: distinct roles for CD54 and B7 molecules. Proc Natl Acad Sci U S A2003; 100: 6670–6675.
13.
Utsugi-KobukaiSFujimakiHHottaC: MHC class I-mediated exogenous antigen presentation by exosomes secreted from immature and mature bone marrow derived dendritic cells. Immunol Lett2003; 89: 125–131.
14.
WolfersJLozierARaposoG: Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med2001; 7: 297–303.
15.
AndreFSchartzNEMovassaghM: Malignant effusions and immunogenic tumour-derived exosomes. Lancet2002; 360: 295–305.
16.
EscudierBDorvalTChaputN: Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of the first phase I clinical trial. J Transl Med2005; 3: 10.
17.
MorseMAGarstJOsadaT: A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer. J Transl Med2005; 3: 9.
18.
DaiSWeiDWuZ: Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer. Mol Ther2008; 16: 782–790.
19.
LamparskiHGMetha-DamaniAYaoJY: Production and characterization of clinical grade exosomes derived from dendritic cells. J Immunol Methods2002; 270: 211–226.
20.
KaurRRajeM: A solid-phase method for evaluation of gold conjugate used in quantitative detection of antigen by immunogold-labeling electron microscopy. J Immunol Methods2003; 279: 33–40.
21.
BielSSNitscheAKurthA: Detection of human polyomaviruses in urine from bone marrow transplant patients: comparison of electron microscopy with PCR. Clin Chem2004; 50: 306–312.
22.
HoenEN Nolte-'tBuschowSIAndertonSM: Activated T cells recruit exosomes secreted by dendritic cells via LFA-1. Blood2009; 113: 1977–1981.
23.
Arnold-SchildDHanauDSpehnerD: Cutting edge: receptor-mediated endocytosis of heat shock proteins by professional antigen-presenting cells. J Immunol1999; 162: 3757–3760.
24.
GastparRGehrmannMBauseroMA: Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells. Cancer Res2005; 65: 5238–5247.
25.
VegaVLRodríguez-SilvaMFreyT: Hsp70 translocates into the plasma membrane after stress and is released into the extracellular environment in a membrane-associated form that activates macrophages. J Immunol2008; 180: 4299–4307.
26.
DaiSWanTWangB: More efficient induction of HLA-A*0201-restricted and carcinoembryonic antigen (CEA)-specific CTL response by immunization with exosomes prepared from heat-stressed CEA-positive tumor cells. Clin Cancer Res2005; 11: 7554–7563.
27.
DouerD: New advances in the treatment of acute promyelocytic leukemia. Int J Hematol2002; 76 (suppl 2): 179–187.
28.
EsteveJEscodaLMartínG: Outcome of patients with acute promyelocytic leukemia failing to front-line treatment with all-trans retinoic acid and anthracycline-based chemotherapy (PETHEMA protocols LPA96 and LPA99): benefit of an early intervention. Leukemia2007; 21: 446–452.
29.
ThéryCOstrowskiMSeguraE: Membrane vesicles as conveyors of immune responses. Nat Rev Immunol2009; 9: 581–593.
